A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China
- Status
- COMPLETED
- Phase
- N/A
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012)
- Status
- COMPLETED
- Phase
- PHASE1
STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012
- Status
- COMPLETED
- Phase
- N/A
A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045)
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
"Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk"
- Status
- COMPLETED
- Phase
- N/A
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Vaccinations and People With Disabilities
- Status
- RECRUITING
- Phase
- N/A
Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE2